Contemporary treatment options for prostate cancer are considered to have comparable efficacy. Therefore other differences such as treatment related toxicities, impact on quality of life, convenience, treatment time, and cost become important considerations in influencing treatment choice.
FREE DAILY AND WEEKLY NEWSLETTERS OFFERED BY CONTENT OF INTEREST
Did you find this article relevant? Subscribe to UroToday-GUOncToday!
The fields of GU Oncology and Urology are advancing rapidly including new treatments, enrolling clinical trials, screening and surveillance recommendations along with updated guidelines. Join us as one of our subscribers who rely on UroToday as their must-read source for the latest news and data on drugs. Sign up today for blogs, video conversations, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.
The goal of brachytherapy is to achieve high precision, targeted radiotherapy utilising advanced computerised treatment planning and image guided delivery systems to achieve tailored ablative tumour dose to the prostate whilst sparing surrounding organs at risk to minimise potential toxicities. This article is protected by copyright. All rights reserved.BJU international 2015 Aug 11 [Epub ahead of print]
Michael Wt Chao, Peter Grimm, John Yaxley, Raj Jagavkar, Michael Ng, Nathan Lawrentschuk
Radiation Oncology Victoria, Ringwood East, Victoria, Australia , Prostate Cancer Center of Seattle, Seattle, WA, USA , The Wesley Hospital, Brisbane, Queensland, Australia , St Vincent's Hospital, Darlinghurst, NSW, Australia , Radiation Oncology Victoria, Epping, Victoria, Australia , Department of Surgery and Olivia Newton John Cancer Research Institute, Austin Hospital and Peter MacCallum Cancer Centre, Department of Surgical Oncology, Victoria, Australia